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Abstract.  The oligodendrocyte-derived extracellular 
matrix glycoprotein J1-160/180 is a recognition mole- 
cule expressed exclusively in the central nervous sys- 
tem. J1-160/180 has been shown to be adhesive for 
astrocytes and repellent towards neurons and growth 
cones. We report here the complete nucleotide se- 
quence of J1-160/180 in the rat.  The predicted amino 
acid sequence showed a structural architecture very 
similar to tenascin: a cysteine-rich amino terminal re- 
gion is followed by 4.5 epidermal growth factor-like 
repeats, 9 fibronectin type III homologous repeats and 
a domain homologous to fibrinogen. Sequence com- 
parison analysis revealed highest homology of rat J1- 
160/180 to mouse tenascin and chicken restrictin with 
a similarity of 66%  and 85%, respectively.  The J1- 
160/180-coding  mRNA is derived from a single copy 
gene. Using the polymerase chain reaction we could 
show that two J1-160/180 isoforms are generated by al- 
ternative splicing of the sixth fibronectin type III ho- 
mologous repeat.  Localization of J1-160/180 mRNA by 
in situ hybridization in the cerebellum, hippocampus 
and olfactory bulb confirmed the expression of Jl-160/ 
180 by oligodendrocytes with a peak of transcription 
at 7-14 d after birth, indicating a functional role dur- 
ing myelination. In addition, Jl-160/180-specific  RNA 
was found in a small subset of neurons in all three 
structures of the CNS analyzed. These neurons con- 
tinue to express J1-160/180 in the adult. 
C 
ELL-cell  and  cell-extracellular  matrix interactions 
have been shown to play crucial roles in the develop- 
ment and maintenance of a multiceUular organism. 
The search for the molecular basis of these interactions led 
to the characterization of an increasing number of adhesion 
molecules  (for reviews see Edelman,  1986; Jessell,  1988; 
Schachner,  1990, 1991). Recently, it has become clear that 
not only adhesive, but also inhibitory or repellent processes 
represent  important  features  of active  cell-cell and cell- 
extracellular matrix interactions (for review see Keynes and 
Cook, 1992). Several molecules have been identified which 
are involved in the inhibition of neural interactions, demon- 
strable as local paralysis of  growth cone motility followed by 
growth cone collapse (Cox et al., 1990; Davies et al., 1990; 
Schwab, 1990). Both adhesive and repellent properties have 
been  demonstrated  for  the  extracellular  matrix  proteins 
tenascin and J1-160/180 (Pesheva et al., 1989; Spring et al., 
1989; Falssner and Kruse,  1990; Morganti et al.,  1990). 
Tenascin, also known as hexabrachion, cytotactin and J1- 
200/220 (for review see Erickson and Bourdon,  1989), and 
J1-160/180 constitute members of the J1 family of extracellu- 
lar matrix glycoproteins. The members of the J1 family were 
first described as neural adhesion molecules involved in the 
short-term  interaction  between  neurons  and  glial  cells 
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(Kruse  et  al.,  1985). In electron  micrographs  of rotary 
shadowed molecules, tenascin appears as hexamers (Erick- 
son  and  Iglesias,  1984), whereas  J1-160/180 consists  of 
trimers (Jl-180) and dimers or monomers (Jl-160) (Pesheva 
et al., 1989). During development, there is a shift from the 
higher (tenascin) to the lower J1-160/180 molecular weight 
forms, resulting in hardly detectable levels of tenascin in the 
adult brain.  Tenascin is expressed widely by fibroblasts, as- 
trocytes, and Schwann cells (Gatchalian et al., 1989; Faiss- 
ner et al.,  1988; Seilheimer and Schachner,  1988; Bartsch 
et al., 1992), whereas J1-160/180 has been reported to be an 
oligodendrocyte-derived  molecule  (Pesheva et al.,  1989). 
Beside these differences structural  similarities between J1- 
160/180  and  tenascin  have  been  shown  to  exist  by  im- 
munochemical  methods (Faissner et al.,  1988; Pesheva et 
al.,  1989) and similar functional properties  have been de- 
scribed in vitro (Faissner and Kruse,  1990; Pesheva et al., 
1989; Taylor, J., P. Pesheva, M. Schachner, submitted for 
publication). 
The similar functional and structural properties of tenas- 
cin and J1-160/180 led to the question, whether these similar- 
ities are due to common structural motifs. Therefore, we iso- 
lated a Jl-160/180-specific cDNA clone from an expression 
library  of rat  spinal  cord  oligodendrocytes  (Fuss  et al., 
1991). Here we report the complete coding sequence of rat 
J1-160/180 as determined from this cDNA clone and from a 
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and  encoding  the  5' end  of the  molecule.  The predicted 
amino acid sequence revealed highest homology to the se- 
quences of mouse tenascin (Weller et al., 1991) and chicken 
restrictin  (N6renberg  et  al.,  1992),  with  a  structural ar- 
chitecture common to all three molecules. The existence of 
at least two JM60/180 isoforms, identified by PCR, suggests 
that, in analogy to the isoforms of tenascin,  the difference 
between JM60 and Jl-180 may be due to alternative splicing. 
The localization of  JM60/180 mRNA in the cerebellum, hip- 
pocampus,  and  olfactory  bulb  by  in  situ hybridization 
confirmed the expression of Jl-160/180 by oligodendrocytes. 
In  addition,  some  neurons  were  shown  to  express  J1- 
160/180-coding  mRNA in all three brain regions that were 
analyzed.  Some of these results have been reported previ- 
ously in abstract form (Fuss and Schachner,  1991). 
Materials and Methods 
DNA Sequence Analysis 
DNA was sequenced  by the dideoxynucloatide  chain-termination method 
described by Sanger (1977) with douhle-stranded Bluescript clones as tem- 
plates using T7 DNA polymerase (Pharmacia LKB, Uppsala, Sweden). The 
sequence  of the  eDNA  clone  was  determined by  constructing nested 
unidirectional  deletions using r  HI (Pharmacia LKB).  Subse- 
quently, parts of the sequence which were still missing were determined by 
using  specific  oligonuclcotides  as  primers.  For  sequence  analysis  the 
UWGCG Sequence Analysis Software Package (Devereux et al., 1984) was 
used. 
Polymerase Chain Reaction 
Amplification of the 5' end of the Jl-160/180-coding  sequence,  which was 
missing in the eDNA clone originally described (Fuss et al., 1991) and am- 
plification of the alternatively spliced FNIH repeat was achieved by the PCR 
(Salki et al., 1988) on reverse transcribed RNA, synthesized with Moloney 
murine leukemia  virus RNase H- reverse  transcriptase according  to the 
manufacturer's  instructions (Gibco/BRL, Basel, Switzerland). 
For amplification of the 5' end the following oligonucleotides  were used: 
5'-GGACATAGTCCAGTTGTCCTGTGG-C-3' (nucleotide [nt]  675-651  in 
Fig.  1) as primer for the single stranded eDNA synthesis;  5'-AACTTC- 
TGTCTGTATGTGTTCTAGC-Y, synthesized according to the sequence of 
the genomic mouse J1-160/180  clone (kindly provided by Dr. Dirk Montag, 
in this department) as 5' primer and 5'-GCATCTCGATTCGCKTICAAC-Y 
(nucleotides  589-570 in Fig.  1) as T-primer. The amplifying reaction was 
carried out in the presence of 1.5 mM MgCI2 by repeating the cycle (93~ 
for 1 rain, 55~  for 1 min, and 720C for 3 min) 25 times. 
For amplification of the alternatively spliced fibronectin  type III (FNHI) 
repeat, the oligonucleotide  5"GTGGAGAAGTTC-d3"IVaC~GAT-Y  (nt 3268- 
3249 in Fig.  1) was used as primer for single stranded eDNA synthesis, 
5'-C'II3ACAGATCTAGAGCC~CJCAG-3' (nt 2376-2400  in Fig.  1) as 
Y-primer and 5'-CT'IGGGTGGTCGATAGGATACTCGA-3'  (nt 2860-2839 
in Fig. 1) as Y-primer. The cycle (93"C for 1 min, 68~  for 1 min, and 720C 
for 5 min) was repeated 35 times in the presence of 0.5 mM MgC12. Anal- 
ysis of PCR products was performed after reannealing to remove artificial 
beteroduplices  according to the method described by Wenger et al. (1991). 
Southern Blot Analysis 
Isolation of genomic DNA was performed in combination with the purifica- 
tion of RNA according  to the method of Chirgwin et al. (1979; see also 
Sambrook et al.,  1989) by omitting steps that could lead to sheared DNA. 
15 #g DNA were used for digestion with various restriction enzymes each. 
The DNA fragments were separated on a 0.8 % agarose gel and subsequently 
1. Abbreviations used in this paper:  CNS,  central nervous system; FNHI, 
fibronectin type HI;  GABA, ),-amino  butyric acid;  J,  JM60/180; MAG, 
myelin-associated  glycoprotein;  nt, nuclentides; PCR, polymerase chain 
reaction. 
transferred to Biodyne A nylon membranes (Pall, Dreieich, Germany). For 
hybridization,  a  122-bp fragment, representing nt 558-680  of the rat J1- 
160/180 sequence  (see Fig.  1), was labeled with digoxigenin-ll-dUTP ac- 
cording to the manufacturer's  instructions (Boehringer Maanheim GmbH, 
Maanheim, Germany). Hybridization was carded out in 50% formamide 
at 42~  The washing conditions were the following:  two washings, each 
at room temperature,  in 2x SSC (0.3 M NaCl/0.03 M Na-citrate,  pH 7.5) 
containing 0.1% SDS; and two washings at 65"C in 0.5x  SSC containing 
0.1% SDS.  For detection of bound DNA, antidigoxigenin  antibodies cou- 
pled  with  alkaline  phosphatase  and  the  chemiluminescent  substrate 
AMPPD (3  - [2"spiroadamantane]-4-methoxy-4-(3~-phospboryloxy)-phenyl - 
1,2-dioxetane)  were used as described (Boehringer Mannheim GmbH). 
In Situ Hybridization 
For in situ hybridization,  digoxigenin-ll-UTP-labeled cRNA probes (an- 
tisense and sense) were generated according to the manufacturer's  instruc- 
tions (Beehringer Mannheim GmbH) and hydrolyzed under alkaline condi- 
tions to obtain fragments of '~250 nt in length. The Jl-160/180-specific 
cRNA probe represents the entire length of the eDNA clone originally iso- 
lated (Fuss et al.,  1991). The cRNA probe specific for myelin-associated 
glycoprotein  (MAG) represents the whole coding region of the 72-kD pro- 
tein (Lai  et al.,  1987) and was kindly provided by Ulrich Dtrries (this 
department).  The  cRNA  probe  specific  for  L1  (Moos  et  al.,  1988) 
represents the amino-terminal part of the protein including the first 2.5- 
immunoglobulin (Ig)-like domains and was kindly provided by Hasan Mo- 
hajeri (this department). Negative controls, hybridized  with the respective 
sense cRNA probes, showed no significant  signals. 
Fixation and hybridization of fresh-frozen  cryostat sections was carried 
out as described previously  (Bartsch  et al.,  1992).  Briefly, sections  were 
thaw mounted onto 3-aminopropyltriethoxy-silane-coated  coverslips  and 
fixed in 4% paraformaldehyde  in PBS, pH 7.3. After treaffnent with 0.1 M 
HCI  and subsequently with 0.1  M  tfiethanolamine, pH  8.0, containing 
0.25% acetic anhydride,  sections were dehydrated in an ascending alcohol 
series.  Prehybridization and hybridization were carried out in 50% forma- 
mide at 55~  Washing conditions were as follows: two washings in 0.2x 
SSC and three washings in 0.1x SSC containing 50% formamide at 55~ 
Detection of bound cRNA was performed by incubation with alkaline phos- 
phatase-coupled antibodies to digoxigenin  and subsequent development 
with NBT (4-nitroblue tetrazolium chloride) and BCIP (5-bromo-4-chloro- 
3-indolylphosphate)  in the presence of levamisol. 
Cell Suspensions 
Cerebella, hippocampi,  and olfactory bulbs were carefully prepared from 
2-wk-old rats, avoiding contamination with tissues adherent to these brain 
regions.  Tissues  were cut into pieces,  incubated in Ca  2+- and Mg2+-free 
(CMF) I-IBSS  containing 0.1% DNase,  1% trypsin for 15 rain at room tem- 
perature and resuspended in CMF-I-IBSS containing 0.05 % DNAse.  After 
pipetting up and down with a fire-polished  glass pipette,  cell suspensions 
were washed with CMF-I-IBSS and plated on glass coverslips coated with 
Cell-Tak (Collaborative  Research  Incorporated, Bedford,  MA). After 2 h 
cells were fixed in PBS, pH 7.3, containing 4% paraformaidehyde  and used 
for in situ hybridization and indirect immunofluorescence  as  described 
(Wintergerst et ai.,  1993). For indirect immunofluorescence,  the mAb D3 
(Schlosshauer,  1989) and a mixture of mAbs SMI-31 and SM-32  (Stern- 
berger Monoclonals Inc., Baltimore, MD) were used, recognizing N-CAM- 
180, the neuron-specific  isoform of N-CAM (Noble et al.,  1985) and the 
phosphorylated and non-phosphorylated forms of neurofilament,  respec- 
tively. Primary antibodies were visualized by FITC-conjugatod  goat anti- 
mouse (Dynatech Laboratories, Inc., Alexandria,  VA) IgG antibodies. 
Results 
Sequence Analysis ofj1-160/180 
Isolation and identification of the rat eDNA clone encoding 
almost the whole coding region of JM60/180  has been de- 
scribed previously (Fuss et al., 1991). The clone was iden- 
tiffed as J1-160/180 specific by the following criteria: First, 
the fusion protein encoded by this eDNA clone is recognized 
by  three  different Jl-160/180-specific  mAbs;  second,  the 
eDNA clone contains the nucleotide sequence coding for an 
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terminal amino acid sequence derived from a tryptic peptide 
of  the mouse Jl-160 glycoprotein;  third, Northern blot analy- 
sis revealed that  the tissue distribution  and developmental 
occurrence of the mRNA recognized by the eDNA  clone is 
in agreement with previous immunocytochemical and im- 
munoehemieal observations.  The sequence of this  eDNA 
clone is represented by nucleotides 509-6455 in Fig.  1. The 
missing amino-terminal  sequence was determined by using 
PCR with a 5' primer derived from the genomic mouse J1- 
160/180 sequence and reverse transcribed RNA from the 
brains of 15-d-old rats. The resulting PCR fragment of 603 
bp was cloned into a Bluescript vector to determine the rat- 
specific  amino-terminal  sequence of J1-160/180. The pre- 
dicted ATG start codon at nucleotide positions 159-161 (Fig. 
1) is flanked by the most conserved nucleotides of the con- 
sensus sequence for translation  initiation  sites in eukaryotes 
(Kozak, 1984). This location is further confirmed by the ex- 
istence of stop codons in all three reading frames further up- 
stream. The location of the putative signal sequence and the 
first amino acid of the mature protein at residue 32 was 
predicted according to the method of von Heijne (1988) and 
from the hydrophobicity profile (Kyte and Doolittle, 1982; 
and data not shown) of the translated  sequence which indi- 
cates one hydrophobic  region at the amino terminus (resi- 
dues 9-25; Fig.  1). A potential polyadenylation signal  fol- 
lowed by a  poly(A)  tail  could  not be found within  the 
Y-untranslated  sequence. The deduced amino acid sequence 
revealed a protein of 1,356 amino acid residues (Fig.  1) with 
a predicted molecular mass of 149 kD. 
The J1-160/180 sequence is composed of different  mod- 
ules: a cysteine-rich  amino-terminal  region, followed by 4.5 
EGF-like domains,  9 FNIII repeats,  and a domain homolo- 
gous to fibrinogen.  This modular structure is very similar to 
the one described for tenascin in different species (Spring et 
al.,  1989; Jones et al.,  1989, Weller et al.,  1991). Mouse 
tenascin shows an overall identity of 47% and a similarity 
of 66% to rat J1-160/180, whereby calculation of the similar- 
ity takes into account mismatches based on the evolutionary 
distance between the amino  acid residues  (Gribskov and 
Burgess,  1986). Comparison of the rat J1-160/180 sequence 
with the recently published sequence of the 170-kD extracel- 
lular matrix molecule chicken restrictin (NSrenberg  et al., 
1992) revealed an overall similarity  of 85% and an identical 
modular structure. 
It has been shown for tenascin,  but not for restrictin that 
alternatively  spliced FNIII repeats are inserted between the 
fifth and third  last FNIII repeat (see Fig.  9) (Prieto et al., 
1990; Gulcher et al.,  1991; Siri et al.,  1991; Weller et al., 
1991). The alignment  of the FNIII repeats of rat J1-160/180 
showed that the first five repeats correspond to the first five 
and the last three correspond to the last three FNIII repeats 
of mouse tenascin,  whereby each repeat in rat J1-160/180 is 
more homologous to the corresponding  repeat in  mouse 
tenasein than  to one of its  own repeats (Fig.  2).  Similar 
results  were obtained for chicken  restrictin,  where each 
FNIII repeat is more similar to a repeat in chicken tenasein 
than to one of its own repeats (Ntrenberg et al., 1992). The 
only exception to this principle is represented by the sixth 
repeat of rat J1-160/180 which has no clear counterpart in 
tenascin.  It showed highest  homology to repeat three of 
mouse tenascin with a similarity of 49% and to the third last 
repeat of human tenascin with a similarity  of 55 %. Highest 
homology of the sixth repeat in rat Jl-160/180 with any other 
FNIII repeat of I1-160/180 was found for repeat two with a 
similarity  of 52%. 
Characterization of Two Isoforms of  Rat J1-160/180 
The position of corresponding FNIII repeats in J1-1601180 
and tenascin  suggested the existence of alternatively  spliced 
FNIII repeats in J1-160/180 also. To characterize putative J1- 
160/180 isoforms generated  by alternative  splicing of FNIII 
repeats, PCR was performed using oligonucleotides priming 
in the fifth and seventh repeat of J1-160/180 and reverse tran- 
scribed RNA from brains of 17-d-old embryonic, 15-d-old 
postnatal,  and adult rats. After reannealing three PCR prod- 
ucts were visible at all stages tested (Fig. 3 A). The largest 
product (482 bp) corresponded in size to the product derived 
from the sequence that is represented in the isolated cDNA 
clone (Fig. 3 A, lanes lOOfg, A, P15). Sequence analysis of 
the 215-bp product revealed  an isoform missing  the sixth 
FNIII repeat of J1-160/180 (Fig.  3 B). The additional  PCR 
product of 258 bp showed no significant homology to the J1- 
160/180 sequence, but turned out to be identical to the 5' se- 
quence of rat dynamin-1, a GTP-binding protein (Obar et al., 
1990). 
These results demonstrate that rat brain contains two J1- 
160/180 isoforms derived from a single copy gene (Fig. 4) 
and generated by alternative  splicing of a FNIII repeat at all 
ages studied. 
Localization ofJ1-160/180  mRNA in the 
Cerebellum, Hippocampus, and Olfactory Bulb 
by In Situ Hybridization 
Previous immunocytological and immunohistological  inves- 
tigations  showed  that  J1-160/180 is  associated with oligo- 
dendrocytes in vitro and is predominantly  detectable in my- 
elinated  regions of the CNS in vivo (Pesheva et al.,  1989; 
Morganti et al., 1990). To elucidate whether this immunocy- 
tochemical distribution  of the secreted 11-160/180 glycopro- 
tein reflects the previously concluded synthesis of J1-160/180 
mRNA by oligodendrocytes,  in situ hybridization  experi- 
ments  were performed using  the  immunohistochemically 
well-characterized  cerebellum (Pesheva et al.,  1989). Only 
few J1A60/180-positive  cells were detectable in the cerebel- 
lum of neonatal  rats, predominantly  situated  at the base of 
the cerebellum and in the proximal part of prospective white 
matter tracts extending  into the folia (Fig.  5 A). A similar 
distribution  of positive cells was observed after in situ hy- 
bridization  with the MAG-specifie probe (Fig.  5 B). More 
J1-160/180- than MAG-positive cells were detectable (com- 
pare Fig. 5, A and B). At 7 and 14 days after birth J1-160/180 
mRNA containing  ceils were detectable along  the entire 
length of the developing white matter tracts and in the inter- 
nal granular  layer (Fig.  5, D and G) in a distribution com- 
parable to that  of MAG (Fig.  5,  E  and H).  For both J1- 
160/180 and MAG mRNA, there is an increase in the number 
of positive cells between postnatal days 7 and  14.  In the 
adult,  however,  fewer  cells  were  J1-160/180 than  MAG 
mRNA positive in white matter tracts and  in the internal 
granular  layer, indicating that J1-160/180 expression  in ma- 
ture oligodendrocytes is down regulated. The cellular local- 
ization of J1-160/180 mRNA in developing  and adult white 
matter  supports  the  formerly  suggested  oligodendrocyte- 
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T  T  F  It  L  0  ￿9  ￿9  L  S  Q  Y  S  V  0  A  L  It  P  G  S  It  Y  56% 
ACGRGGT~TCCAT~OCAGTCCGQG~ACCAATGAAAb'TGATGCCTC AAGC~  CC~TA~  1932 
V  S  I  S  A  V  It  G  T  ,N  Z  $  D  A  $  S  T  Q  F  T  T i s  592 
AAATTGATGCI"CCCAA~qA~AG.7'GGGTTCCCG  GACAGCAACTAGCCTTGACCTCCO,  AT  ~TA  2001 
~..  aT.~[--DI'A"  .  "P  K  N  L  It  Y  G  S  R  T  A  T  .  L  D  L  s  W  D  N  615 
ACAG~GA~'T  GAA~r  GA~E  20'70 
$  Z  A  Z  A  O  Z  Y  g  V  V  Y  0  T  L  A  ￿9  r  Q  Y  It  Z  V  638 
T  QCTC~TACCCAA~  ATTGGTCCAACTACCAAG~CTACCCTCACAGATCT~  TCCAGGCA~T  213 ~) 
L  V  ￿9  10  G  I  G  ￿9  T  T  X  T  T  L  T  D  L  V  1'  G  T  E  T  661 
AT~TATCTGCGGTAATGAACTCGA~ACA~ATTCCCGCTACCATC~ATGCCAGGACTG  2208 
G  V  G  I  It  A  V  M  N  $  X  g  I  1  ?  &  T  H  N  A  It  ?l~  684 
m 
AGCTTGACA~TCCCCGA~ACCTC ATGGTLAC)~CTTCCTCAGA~.'n~  ~ATCTCTCTCATCT~  ~  22  '17 
-"lV///~k'--0 l "~'~a  =  ~P  A  D  L  M  V  T  A  '  0  Z  T  $  l  '  L  I  W  T  g  707 
AGGCCAG~CC  TATTGATCACTATCGAATTACTTTTACTCCAT  CTTCTGGGATCTCCTC  ~  234￿9 
&  0  G  P  I  D  It  Y  It  I  T  ￿9  :  r  I  s  G  z  s  s  z  v  :  .730 
C  ~CCTAC~TAGGACTTCATATACACTGACAGATCTAGAGCCT  ~GAGCAGAATAC  ATCA  TCTC~  2415 
V  P  It  0  It  T  It  Y  T  L  T  D  L  It  ￿9  G  A  r  Y  l  I  0  I  .753 
TTACTGCTGAGAGGGGTC~-GIr  J4C~f'.AGAGCC'FGGAGTCTAC'J~T  ~ATOCCTTCAr* ~TT  CCGCCCTIt  2484 
'7'76 
T~ CACTT~-~'~-F~'~ ATGTC~CCTC  CTCCAGTCTCAACATCACCT GGAGT~AT~  2553 
￿9  It  L  It  r  $  It  V  T  S  I  ￿9  V  W  Z  T  tl  S  D  ￿9  ￿9  ￿9  ~  799 
CAG~CAGACT  CATTCTGAACTAC3~CC~T~LGGAGATG  AT  ~AGGT~TCTTGG  2622 
A  D  It  L  l  L  N  Y  ￿9  P  It  D  Z  E  Z  s  H  H  ￿9  V  L  L  D  822 
ATC~ACCA~P~QCCGTCCTA~T~TA~CA~CACTGAATATAT  ACTGAATCTC~TAG  2s 
A  T  g  It  It  A  V  L  H  G  L  0  ￿9  A  T  g  Y  l  V  N  L  V  A  84S 
CTGTCCLTG~C AGTA~CCTCTGAAC C~  AT  AGTG~GT~  CT  AT  C  ACT  ~E  AGGAATTG&T  CC~  27s 
ACATC~AItTTAGCAACb~GACTAAGCACTr  AC  ~TTTCCTC.G~C  ~  ~  2828 
l  T  I  0  14  V  T  It  D  8  L  T  V  0  N  8  ￿9  P  V  A  ￿9  F  D  091 
ATTR~TJU~ATCCTATCC;ACCACCC~  TC~CC;GCTC~CAC~T~GTr~'CC~  ~  2890 
Y  Y  E  Y  t  I  D  B  P  S  G  R  L  0  $  0  V  V  P  N  T  V  T  914 
CAGAGTTCACAATC~CCA~TCTATC  CAGCTAGT  CAAT  ATGAAATAJ~CTCAACAGTG'T~  2967 
Z  r  T  I  T  I  L  !'  P  A  S  0  Y  r  I  0  L  H  8  V  I  G  It  937 
GGGAC~AGAGTGAACQCATCT  GC  J~CC  TG  GTGCAC  AC  AGCC  ATG~AT  AGCCCCAT~AT~TA  )03& 
CC,~CA~'C~CCAIt C,~.~-.CCC~ CCTC  CA~'T~;AIt  C.~C,~CC~  T(;~  ~^T~  3105 
N  l  T  ~  T  Z  A  L  L  0  N  K  A  P  M  G  E  V  Z  N  Y  Y  I  9i3 
t 
TTGTCCTC-~r  ~CATQGCT~CCATCCT~  TGAT  GGGG  TCAGT~AAGAAT  ~  3174 
V  L  T  It  r  A  M  A  G  Z  T  I  L  V  D  G  V  S  Z  IC  F  Q  L  1006 
TT~TAGACCT~TCCTAG~CTAC  J~TGTCACCATGTATGCT AC  CAGTGCACCT~  3243 
V  0  L  L  P  It  T  It  y  T  V  T  M  Y  A  T  0  G  P  L  V  8  G  1029 
GC..ACCAT~RC  CAR~TTCTCCAC  ~  TCCTGGACCCTC  CC  GCCAACCT  C,~CAGC  ~~  3312 
-'--',r ~B  ~  II 
G~GATCTCCT~CAGCCACC  CAGA~  T~AT  TCAAJ~ATGTCTT~ ~A? ~  3381 
O  S  A  L  l  S  M  O  p  p  It  A  A  I  E  N  Y  V  L  T  Y  g  S  1075 
CC.A~CGATC,  GA)~C~CRAEGAG.CTC,,ATTGT  GGAT  GC  TGAD~,ACA~TC~  ACT~  3450 
T  0  G  8  It  K  E  L  1  V  D  A  s  D  T  W  I  It  L  Z  G  L  0  1098 
CQGAGAAr  ~C,  CTCAG  C,,AGGCC  ACAAGGAG~  ~A  3 S  19 
Z  N  T  0  Y  T  Y  L  ~  Q  A  A  0  s  A  T  A  S  S  L  T  S  T  1121 
CTATCTTTACCRC~.GG~CCGGCTGT  TC  TCTC  AT  CCT~AAGACT  GTCr  CA~AT~T~  358 I 
,  r  ,  ,  =  ~-  It  v  r  0  It  ￿9  c  A  o  It  ,...  ~  o  :144 
"-"IV 111 
ACACTCTCAG~TGGA~TI'TACA~ATCT  TCCTCAAT~TTAA  e~  CACAAGTT  ~AT  ~  3657 
T  L  0  G  V  u  T  I  r  L  N  G  Z  L  S  It  X  L  Q  V  Y  C  D  1187 
ATA'I'~-~C  CACAC,  AT~GGGG4~,GC  TGGA  TTGTTTTC  CA  GAGACGGCAAAATGGC  CAAACT~  3726 
M  T  T  D  :  G  G  N  |  V  F  O  It  It  O  N  G  0  T  D  F  T  g  1190 
GGA.AA.7'GGGC2LC,  ATTACCGTGTTGGCTTTGGGAAT  CTC~AGGATGAGTT  TT~  ~~  3795 
X  W  A  D  Y  It  V  G  F  G  N  L  Z  0  E  F  N  L  G  L  D  W  Y  1213 
ACCA~TA~  CAGGGCCCCTAT  GA  GCTG  C~TGT~TAT~T~AC~GTC  3884 
a  It  l  T  A  Q  G  A  Y  s  L  It  V  0  M  It  0  G  G  Z  A  V  r  1236 
TT~ACTATC~CA~  T~  CGCTGTGGLGGACAGC~GAAGCCT GT  A~AAGCTC  CG  TATAGG~A~  3933 
A  ~'  Y  D  g  r  A  V  r  D  S  It  S  L  Y  g  L  It  I  G  G  Y  N  1258 
AT~AC~G~AGAC  TCCC  TTAGCT  AT  CACCA~  ACGT  CCTT  TCTCCACT  ~ ~~  4002 
Q  T  A  G  D  0  L  $  Y  R  O  G  It  P  F  S  T  s  0  It  0  M  D  1282 
ATGTTGCAGTCACCAJ~TGCC  ATGT  CA  TACAAG  GGT~TGGT  G~TATAAGAACT  G~  CA~  40  ? | 
V  A  V  T  N  C  A  M  $  Y  g  G  A  W  W  T  K  N  C  B  It  T  N  1305 
Ar  ~AQTC  ~CAb~CAGG  ~ATCA,~'T~  ~'TAC  CATT  GGAAJ~.~C~  4140 
L  H  G  g  Y  G  g  S  R  ￿9  8  Q  G  1  N  M  y  H  W  g  G  ￿9  E  1328 
AATTCTCC~Tr  ACA~CC  ~  4209 
F  |  I  P  F  V  Z  H  K  )4  R  f  Y  I  I  R  L  T  A  G  R  X  R  1351 
G~R  ~A: ~ TGXJULAFTTC~CTGC~  AGCCA~ACCA~  CAJ~CGAT  CTTTTCTG  TCATTT  ~  4270135' 
GTATTTTATAAT~TGAQACA~GGA~RACJ~GTAATGTGCTTCACAACATATTCAGACTAT  CT  4347 
G~AA~TCAGTTACGTACCATCTG~TCCTAATTTCT~GCCTT~GCCTGACTCTCAGG  4416 
CTACACT~r  GCTARCCAGT  CCT~TGATCACC CCCTCTTTTC~AC J~AGGAGGAAAACTGGC~  4485 
TTAAAACAAJ~ACCGGATC~TAr  4S54 
CCTCT  TCT~ATACTATCCAAC TTCTAA~TAGTAATCT~GCTGACCATGACCAGG~  4623 
r  J~TCCC~TTCAACA~C~TTRGCCAATCTTCTCTTA~A~T&CCCACC  4692 
ACACTCT~CJ~AC~CAJ~ACTT  CAAT  ~GCTA~TTCTCCCATTCTGACACTTAACTT  4781 
TTAC~AAGAOT~CT  TCA~CCCC~CCTCCACTAGATTC  CTCCACTAGA~AT~  ~  4830 
C  AACCCAACTATTGTTTAGAACTCCAGTTACCAAAGCTT  g?CTGATCCTGGCC~T~  4893 
CT~CT~AGTGTCATAA~CTATTGTCAT~RATA~TTTCTTT~GGTC~ACTTGQ~  4950 
ATTCTTTCTAGCACATTT~CACCAG~ATTGACAA~CAG~TAGAAATGAAGGCACCTACC~  5037 
AGT  CCGTAGTC  CCATT~CTGACCTT  CTTTAGTGCTAC  TT~TACATTTA~T~TA~AT  $  I  06 
GGACTCCTTTC~TTCCTAGCTGAAGGTCTCTA~TTCTGT~qCCCItC~'~C AGGCTCTC~  S 175 
GT~CATAAGAATCAG~TrTGTCTGAGCCATTCCCCTGACCTGATT&CCCT~  S  244 
GAC~.AATATT~C~G~A~'TTTT  ~TTF~T  TT~CTT  TGATCCT~TAQTAAACAGAACTGA~  5313 
AT~C~TCAT~__%~_-~_~_%CATTTTCCATCTCC~TCT~ATCCTGCTTT  C~T~  $302 
AGTGCCJ~.AAATT~TTTAGAACTCCAA~A~C~TCTCCCCGGGCCCr  AT~  5451 
TTTGATTTTTAA~ CTQGAGAACT  ~A~ATA~ATGACCTT  TCAGCTTCTCCTCJtAATAAA  .%520 
AN~A;~CC;~I~rTCCCT~  ;~CAI,  ACTCT~CCA;~C.CTTC'~AACT~ ,,.~ i~ ~-..CCr  5589 
CGCTCCCATCTCTGAGGACCCAGT~  TSCT&TA~'z~  ~GTACC~TCTA~GTCTCTTATA~CTG  5658 
TGCCA~TTTCT~  CAAGTTGGCATCTTGA~ TAT~kLATAG~ACCATTTAAT~  ~727 
A~TAb'TCCT~GATGATCACCT~TAQCATCATGACAT~TA~TT  $  ~  88 
TT~TAA~CTCC C~ATTTTT~TGATGCAGACCCAGTGACCT  ATTCRA~CCAAJ~A~  5865 
TTTTCRCTTTTTAAT~TCATGGACTT~AGCT  ATAC~  5534 
T  TATATAA&ATTTAACTAGAT~TAGGr CAACCAT~GAACCAG~TTCA~TTGA  6003 
~=GCTO'~.ATACAGGOCCACCTC~AC~CCAT~ACA~C?ACAAGTCCTrGATGGATTT~TT~  &072 
TOG~C~CT  AGTTGAATTAGAGTTT J~CA~TTTC  TAATGCTCCTTTAGGT  6141 
TAACAG~TAAT~TTTA~  ~'rGAT  AGGAJ~  ACAATCAAJ~TTGGCCTT~RQr  6210 
TAAGGA~CAGAATCTTTGTC~GAT~~AG  627% 
ACTGACTr  634| 
AT~T~AAGTCATTA'I~TCTA~AAAC~.AD~C~TGG~I~TC,  Qtw~RACA~  ~ 41 ? 
CCACCTCAT ~CCG~A  TCTCGTGCCG  AAT~  C  6455 
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mTN  ~VSPPKDLIVTEVTEETVNLAWDN~MRVT~YLIMYT~THADGLEMQFRVPGDQ~TSTT~RELEPGVEYF~RVFAILENKR~IPVSARVAT  FNIII  I 
hTN  ••VSPPKDLwTEVT•ETVNLAWDNEMRVTEYLwYTPTHEGGL•MQFRVPGDQ.••TSTI•RELEPGVEYF•RVFA•LENKK•IPVSARVAT  FNIII  1 
rJ  •HLSTPQGLQ•KTITETT•EV•WEPFSFSFDGWEISF••TPKNNEGGVIAQLP•DV•TSFNQTGLKPGEEYIVNVVALKEQARGPPTSASVST  FNIII  2 
mTN  .YLPAPEGLKF~IK~TSVEVEwDPLDIAFETWEIIFRN~KEDEGEITK~LRRPE~TSYRQTGLAPGQEY~SLHIVKNNTRGPGLK~VTTT  FNIII  2 
hTN  •YLPAPEGLKFKSIKETS•EVEWDPLDIAF•TWEI•FRNMNK•DEGE•TKSLRRPE•TSYRQTGLAPGQE•EISLHIVKNNTRGPGL•RVTTT  FNIII  2 
rJ  .VIDGPTQIL~RDVSDTVAFVEWTPPRAKVDFILLKYGL~GGEGGKTTFRLQPPL~.S~Y~V~ALRPGSRYEVSISAVRGTNESDASST~FTT  FNIII  3 
mTN  .RLDAPSHIEVKDVTDTTALITWFKPLAEIDSI•LSYGIKDVPGDRTTIDLTHED••NQYSIGNLRPDTEYEVSLISRRVDMA•NPA••TFIT  FNIII  3 
hTN  .RLDAPSQIEVKDVTDTTALITWFKPLAE~DG~ELTYGIKDVPGDRTTIDLT~DE..NQu  FNIII  3 
rJ  ••IDAPKNLRVGSRTAT•LDLEWDNSEAEA•EYKVVY•TLAGE•Y••VLVPKGIGPTTKTTLTDLVPGT•YGVGISAVMNSKQSIPATMNART  FNIII  4 
mTN  •GLDAPRNLRR•S•TDNSITL•WRNVKADIDSYRIKYA•ISGGDHAEIDVPKSQ•ATTKTTLTGLR•GT•YGIGVSAV•GD•ESDPATINAAT  FNIII  4 
hTN  ~GLDAPRNLRRV~QTDNSITLEWRNGKAAIDSYRIKYAPISGGDHA~VD~PKSQQATTKTTLTGLRPGTE~GIGVSAVNED~ESNPATINAAT  FNIII  4 
rJ  .ELDSPRDLMVTASSETSISLIWTKASGPIDHYRITFTPSSGISSEVTVPRDR  ....  TSYTLTDLEPGAEYIISITAERGRQQSLESTVDAFT  FNIII  5 
mTN  .EIDAPKDLRVSETTQDSLTFFWTTPLAKFDRYRLNSSLPTGHSMEVQLPKDA  ....  TSHVLTDLEPGQEYTVLLIAEKGRHKSRPARVKAST  FNIII  5 
hTN  .ELDTPKDLQVSETAETSLTLLWKTPLAKFDRYRLNYSLPTGQWVGVQLPRNT  ....  TSYVLRGLEPGQEYNVLLTAEKGRHKSKPARVKAST  FNIII  5 
rJ  •GIDPPKNITISNVTKDSLTVSWSPPVAPFDYYEYPIDHPSGRLDS•V•VPNTV..•T•FTITRLY•ASQYEISLNS•RGREESERICTLVHT  FNIII  7 
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hTN  •AMGSPK•VIFSDIT•NSATVSWRApTAQV•SFRITY•PITGGTPSMVTVDGTK•.•TQTRLVKLIPGVEYLVSIIAMKGFEESEP•SGSFTT  FNIII  13 
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mTN  .ALDGPSGLLIANITDSEALAMWQPAIATVDSYVISYTGERVPEVTRTVSGNTV  ....  EYELHDLEPATEYILSIFAEKGQQKSSTIATKFTT  FNIII  12 
hTN  .ALDGPSGLVTANITDSEALARWQPAIATVDSYVISYTGEKVPEITRTVSGNTV  ....  KYALTDLEPATEYTLRIFAEKGPQKSSTITAKFTT  FNIII  14 
rJ  .LLDPPANLTASEVTRQSALISWQPPRAAIENYVLTYKSTDGSRKELIVDAEDT  ....  WIRLEGLSENTDYTVLLOAAQEARRSSLTSTIF.T  FNIII  9 
mTN  .DLDSPREFTATEVQSETALLTWRPPRASVTGYLLVYESVDGTVKEVIVGPDTT  ....  SYSLADLSPSTHYSARIQALSGSLRSKLIQTIFTT  FNIII  13 
hTN  .DLDSPRDLTATEVQSETALLTWRPPRASVTGYLLVYESVDGTVKEVIVGPDTT  ....  SYSLADLSPSTHYTAKIQALNGPLRSNMIQTIFTT  FNIII  15 
P  W  L  Y  T  CONSENSUS 
Figure 2. Alignment of the constitutive FNIII repeats between rat J1-160/180 (rJ) and mouse (mTN) and human (hTN) tenascin. The RGD 
in the third FNIII repeat of the human sequence is marked by a surrounding box. Conserved amino acid residues are given in the last 
row and marked by a star. The alignment was performed with the program "pileup" of the UWGCG DNA analysis software package. 
specific expression of J1-160/180. No expression by Golgi 
epithelial cells could be detected at any stage. These ceils 
represent a  subclass of cerebellar astrocytes which can be 
unequivocally identified by the position of their cell bodies, 
intercalated among the unlabeled cell bodies of Purkinje 
cells. 
Synthesis  of J1-160/180  mRNA  was,  however,  not  re- 
stricted  to  oligodendrocytes.  J1-160/180  mRNA-positive 
cells were also seen in the molecular layer and first detect- 
able at 7 d after birth in a row of cells just above the Purkinje 
cell layer (Fig. 5 D). At 14 d after birth, the hybridization 
signal spread more upwards in the molecular layer towards 
the meninges (Fig. 5 G). In the adult, Jl-160/180-positive 
cells  covered  almost  the  whole  molecular  layer,  fading 
slightly towards the meninges (Fig. 5, K and L). These J1- 
160/180--positive cells in the molecular layer showed a simi- 
lar distribution as Ll-positive ceils in adjacent sections (com- 
pare Fig. 5, G and I). Since L1 is specifically expressed by 
postmitotic neurons (Rathjen and Schachner, 1984; Persohn 
and Schachner, 1987) and since no other cell types have their 
cell bodies in the molecular layer, the position, size, and den- 
sity of the labeled cells unequivocally identifies them as the 
basket and stellate cells, the small inhibitory interneurons of 
the cerebellar cortex (Palay and Chan-Palay, 1974; Altman, 
1982).  In  contrast to  oligodendrocytes, expression of J1- 
160/180  mRNA  in  these  neuronal  cells  was  not  down- 
regulated in the adult (Fig. 5 K, L). Purkinje and granule cell 
neurons were J1-160/180 mRN  A negative at all developmen- 
tal stages studied. 
To further investigate the cell type-specific expression of 
J1-160/180, we performed in situ hybridization experiments 
with two other, anatomically well characterized structures of 
the CNS, the hippocampus, and olfactory bulb. Studies were 
carried out at different postnatal stages, including the adult. 
In the following, only the results observed in 14-d-old ani- 
mals will be documented. 
Jl-160/180-positive cells in the funbria and fornix, which 
are composed of myelinated fibers, were already detectable 
in 2- and 6-d-old animals (not shown) in a distribution simi- 
lar to the one of MAG-positive cells in  14-d-old animals 
(Fig. 6, E and F). No MAG expressing cells were visible at 
the younger developmental stages. In 14-d-old animals there 
were  more  Jl-160/180-positive  than  MAG-positive  cells 
in the white matter of fimbria and fornix (compare Fig. 6, 
A and B with E and F). In the adult, a reduction in number 
of Jl-160/180-positive cells were seen (not shown). 
Figure 1. DNA and deduced amino acid sequence of J1-160/180. The hydrophobic region corresponding to the putative signal sequence 
is underlined. The beginning of the homologous repeats, EGF-like domains (EGF  1-5), FNIII repeats (FNIII 1-9) and the domain homol- 
ogous to fibrinogen (b'G), are indicated by arrows. The cysteine residues in the amino terminal region are encircled. The terminal stop 
codon (TGA) is marked by a surrounding box. Potential N-glycosylation  sites are marked by a star. These sequence data at the nucleotide 
level are available from EMBL/GenBank/DDBJ under accession number Z18630. 
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existence  of an alternatively  spliced FNIII repeat could be demon- 
strated by PCR using the oligonucleotides  represented  by the under- 
lined sequences in B and total RNA from 17-d-old embryonic (A, 
E/7),  15-d-old  (A, P15) and adult rats  (A, A) as indicated  above 
each lane. Control amplifications  were performed without template 
(A,-) and with 1 fg (A, lfg), and 100 fg (A, 100J~) of  the isolated 
eDNA clone as template.  The amplification products were analyzed 
after reannealing.  In A, the  1.5% agarose gel of these  products, 
stained with ethidium bromide is shown. The molecular weights of 
the fragments obtained are marked at the right margin in base pairs 
(bp). The nucleotide and derived amino acid sequences of the 215- 
bp PCR product is shown in B. The arrows mark the FNIII repeats 
represented by the sequence according to the numerical order given 
in Fig.  1. 
Figure 4. The/1-160/180-spe- 
cific eDNA is derived  from a 
single copy gene. Total geno- 
mic  rat  DNA  was  digested 
with the Eco RV, Pvu H, and 
Sac I as indicated  above each 
lane.  Hybridization was  per- 
formed with a digoxigenin-11- 
dUTP-labeled  122-bp  frag- 
ment representing  nucleotides 
558-680 of the rat/1-160/180 
sequence  shown  in  Fig.  1. 
Specifically  bound,  labeled 
DNA was detected  by chemi- 
luminescence.  The molecular 
weight markers are indicated 
at the right margin in kb. 
Pyramidal cells of  the hippocarnpal fields CA1, CA2, CA3, 
and  granule  cells  of  the  dentate  gyrus  were  J1o160/180 
mRNA-negative at  all  developmental  stages  tested.  How- 
ever, some cells in the hilus of the dentate gyrus became J1- 
160/180 mRNA positive in 6-d-old animals, a developmental 
stage where the dentate gyrus becomes a distinct anatomical 
structure (Altman and Bayer, 1975). These cells are also J1- 
160/180 mRNA positive in 14-d-old (Fig. 6, A, B, and H) and 
adult animals (not shown) in a distribution similar to the one 
of Ll-positive neurons (compare Fig. 6, Hand G). Since the 
Jl-160/180-positive hilar region of  the dentate gyrus is popu- 
Figure 5. Localization of  J1o160/180 (J)- (A, D, G, K, and L), MAG- (B, E, H, and M), or L1- (C, F, and I) specific mRNA in the cerebellum 
of neonatal (A-C), 7-d-old (D-F),  14-d-old  (G-l), and adult (K-M) rats.  In neonatal rats,  cells expressing/1-160/180  are restricted  to 
the base of the cerebellum (A) and have penetrated the developing  cerebellum more deeply than cells  containing MAG transcripts  (B). 
In 1-wk-old rats,  numerous/1-160/180- (D), and MAG- (E) positive cells are present at the base of the cerebellum and along the entire 
length of developing  white matter tracts  of the folia.  In difference to MAG positive  cells,/1-160/180  positive  cells  are also detectable  in 
the internal  granular layer. In the cerebellar cortex of 2-wk-old animals,  a J1-160/180 signal becomes visible in the developing  molecular 
layer (G). In contrast to the L1 (I) signal present in basket and stellate cells,  the/1-160/180  signal appears to be more restricted  to cells 
located just above the Purkinje cell layer. Cells expressing  MAG (H) are present in the internal  granular layer, although not as numerous 
as cells expressing  J1-160/180. In adults,  the number of cells containing/1-160/180 (K) transcripts  and their labeling  intensity  decreased 
in white matter tracts and in the internal granular layer. In contrast, the number of  labeled cells located in the molecular layer (K) increased 
when compared with 2-wk~  animals  (G). They were detectable over the entire width of the molecular layer (L) with a signal intensity 
similar to that observed in 2-wk-old animals.  Sections incubated  with/1-160/180-  (3/), MAG- (O), or LI- (P) sense cRNA probes showed 
no labeling.  Bars:  (A-C, and D-F) 300 #m; (G-l, K, and M) 400 #m; and (L, and N-P)  100/zm. 
The Journal of Cell Biology, Volume 120, 1993  1242 Fuss et al. Molecular Characterization ofJ1-160/180  1243 l~gure 7. Localization of  J1-160/180 (J)- (A), MAG- (B), and L1- (C) specific mRNA in consecutive sections in the olfactory bulb of 14-d-old 
rats by in situ hybridization. Cells that are strongly labeled with the J1-160/180 cRNA probe are mainly located in the internal granular 
layer whereas only few labeled cells are visible above the mitral cells layer (A) with a distribution very similar to that of MAG expressing 
cells (C). In addition, cells that are weakly labeled with the J1-160/180 probe are located in the mitral cell layer, external plexiform layer 
and in a periglomerular position (A). The distribution of  these cells is similar to that of  cells expressing Ll-specific mRNA (C). Bar,  0.5 mm. 
lated by several neuronal cell types  (Amaral  and  Witter, 
1989), a more precise characterization by solely anatomical 
criteria was not possible. A few Jl-160/180-positive signals 
were also detectable in hippocampal layers below and su- 
perficial to the pyramidal cell layer, the stratum oriens, stra- 
tum radiatum, and stratum lacunosum-moleculare (Fig. 6, A 
and B).  The distribution of these cells was comparable to 
that of Ll-positive cells in adjacent sections (compare Fig. 
6, A, B, and H  with C, D, and G, respectively). Thus, we 
conclude that not only in the cerebellum, but also in the hip- 
pocampus  J1-160/180  is  not  exclusively  expressed  by 
oligodendrocytes, but also by certain subtypes of neurons. 
As in the cerebellum, the neuron-derived expression of J1- 
160/180 mRNA  was  not down-regulated in the adult (not 
shown). 
In the olfactory bulb of neonatal rats, cells expressing J1- 
160/180 were only weakly labeled and located mainly in the 
mitral cell layer with a distribution of the hybridization sig- 
nal similar to that of L1 (not shown). Few cells were labeled 
in the internal and external granular layers (not shown). No 
cells were labeled with the MAG anti-sense cRNA probe in 
the olfactory bulb of neonatal rats (not shown). In the olfac- 
tory  bulb  of  14-d-old  rats,  cells  strongly  expressing  J1- 
160/180 mRNA became visible in the internal granular layer 
(Fig. 7 A). Few strongly labeled cells were also detectable 
above the mitral cell layer, in the external plexiform layer and 
in the glomerular layer. In general, cells that were strongly 
labeled with the Jl-160/180 anti-sense cRNA probe were dis- 
tributed in a pattern similar to that of cells containing MAG 
transcripts (Fig. 7  C).  As in the white matter tracts of the 
cerebellum and the fimbria and fornix of the hippocampus 
there were more J1-160/180-  than MAG-positive cells detect- 
able at this stage. 
Cells that were weakly labeled with the J1-160/180 probe 
were located in the mitral cell layer, the external plexiform 
layer and in a periglomerular position (Fig. 7 A) with a distri- 
bution similar to that of cells containing L1 transcripts (Fig. 
7 B). This indicates that the weakly labeled cells correspond 
to neurons. Since there is no neuronal cell type known that 
shows this characteristic distribution, it is not possible to de- 
termine the identity of  the Jl-160/180 mRNA containing neu- 
ronal cell types. The distribution of cells containing the tran- 
scripts of  Jl-160/180,  L1 or MAG in adult animals was similar 
to that of 14-d-old animals, except that the number of  labeled 
ceils was reduced mainly in the granular layer (not shown), 
indicating  that  the  oligodendrocyte-derived,  but  not  the 
neuron-derived expression of  Jl-160/180 is down regulated in 
the adult. 
Characterization ofJ1-160/180  Expressing Cell I)~es 
In Vitro 
To further investigate the cell type-specific expression ofj1- 
160/180 in the three regions of the CNS by in situ hybridiza- 
tion, we hybridized acutely dissociated single cell suspen- 
sions from the cerebellum, hippocampus, and olfactory  bulb 
of 14-d-old rats with the Jl-160/180-specific cRNA probe 
and identified the neurons by indirect immunofluorescence 
with neuron-specific antibodies.  We chose antibodies spe- 
cific for N-CAM 180, the neuron-specific isoform of the neu- 
ral cell adhesion molecule, and neurofilament, since in con- 
trast  to  L1,  the  astrocyte-specific marker  GFAP  and  the 
Figure 6. Localization of J1-160/180 0)- (A, B, and H), MAG- (E and F), and L1- (C, D, and G) specific mRNA in consecutive sections 
of the  14-d-old rat hippocampus by in situ hybridization. In B, D, and F the hippocampal field CA2 and in G and H the denate gyrus 
(C, DG) are presented in higher magnification. Labeled cells are detectable in the white matter (C, win) with the J1-160/180- and MAG- 
specific probe,  whereby more cells are J1-160/180- than MAG-positive (compare A and B with E and F).  In addition,  there are J1- 
160/180-positive signals detectable in a distribution similar to the one of Ll-positive cells in the hilar region (G, h compared to H) of 
the dentate gyrus, the stratum oriens (D, o compared to B) and the stratum radiatum of the hippocampus (D, r compared to B). Pyramidal 
cells of the pyramidal layer (/9 and G, p eornpared to B and H), and granule cells of the granular layer (G, g compared to H) of the dentate 
gyrus are Jl-160/180-negative. Bar: (A, C, and E) 360 gm; (B, D, and F) 90 gm; and (G and H) 15 gm. 
Fuss et al. Molecular Characterization  ofJ1-160/180  1245 Figure 8. Identification of I1-I60/180 mRNA expressing cell types by in situ hybridization in acutely dissociated single cell suspensions 
of  cerebellum (A-C), hippocampus (D-F), and olfactory bulb (G-l) of 14-d-old rats using antibodies to neurofilament  by indirect immuno- 
fluorescence (A-l). Cells from the three brain regions contained cells expressing 11-160/180 mRNA (A, D, and G, arrows) and some but 
not all 11-160/180 expressing  cells were also neurofilament  positive (B, E, and H, arrows). The less uniform  labeling  pattern of  neurofilament 
immunofluoreseence  of 11-160/180 mRNA positive cells is the result of quenching by the alkaline phosphatase reaction product. This is 
evident from the complementarity of the two labels. Cell suspensions incubated with 11-160/180 sense cRNA (K) or cell suspensions in 
which primary antibodies were omitted (L) showed no labeling. (7, F,/, and M represent the phase contrast microphotographs to corre- 
sponding in situ hybridization  and immunofluorescence  images shown  in A and B, D and E, G and H, and K and L, respectively.  Bar, 25/~m. 
oligodendroeyte-specific marker MAG the epitopes recog- 
nized by these antibodies were not destroyed  or did not disap- 
pear during the treatment used for preparation of the single 
cell suspensions. 
In the single cell suspensions of all three CNS regions, 
there were always some cells detectable that contained J1- 
160/180 mRNA (Fig. 8, A, D, and G). Many of  these labeled 
cells were at the same time N-CAM  180-  (not shown) or 
neurofilament immunoreactive (Fig. 8, B, E, and H), indi- 
eating that these cells represent nerve cells. These results un- 
equivocally confirm that JI-160/180 is not only synthesized 
by oligodendroeytes, but also by neurons. 
Discussion 
Primary Structure ofJ1-160/180 
As expected from previous immunochemical studies (Kruse 
et al.,  1985; Falssner et al.,  1988),  J1-160/180 and tenascin 
are structurally very similar, with 47%  identity and 66% 
similarity between rat J1-160/180 and mouse tenascin. The 
overall molecular architecture of both molecules is identical 
in that the putative signal peptide is followed by a cysteine- 
rich amino-terminal  region, EGF-like domains, FNIII repeats, 
and a  calcium binding domain homologous to fibrinogen 
(Fig. 9). The lower rnolecular weight of J1-160/180 can be 
explained  by  the  smaller  numbers  of EGF-llke domains 
which amount to 4.5 in rat J1-160/180 and to 14.5 in mouse 
tenascin (Weller et al.,  1991). The recently published se- 
quence of  chicken restrictin (Nfrenberg et al., 1992) showed 
an overall similarity of 85 % to rat J1-160/180 and an identical 
modular structure. As shown for the FNIII repeats in tenas- 
cin of different species, each FNIII repeat in rat J1-160/180 
is more homologous to the corresponding one in chicken re- 
strictin than to one of its own repeats, suggesting that rat J1- 
160/180 and chicken restrictin represent species homologs. 
In  agreement  with  the  extracellular  localization  of  J1- 
160/180,  sequence  analysis  predicts  a  protein  without a 
transmembrane domain. For tenascin, it was suggested by 
protein structure predictions that hydrophobic heptad pep- 
tides in the amino terminal part of the protein are directly 
involved in the association of the monomeric polypeptide 
chains with each other to form a hexameric complex (Spring 
et al.,  1989).  For both tenascin and J1-160/180, cysteine 
residues were suggested to participate in the stabilization of 
the multimeric complex by forming disulfide bridges (Spring 
et al., 1989; Pesheva et al., 1989). The cysteine residues and 
three hydrophobic heptad peptides (residues 134-155) are lo- 
cated in the amino-terminal sequence of J1-160/180 at the 
same positions as in the tenascin sequence (Fig. 9).  It is 
therefore likely that these structures are also involved in the 
formation of the trimers and dimers of J1-160/180. 
J1-160/180 Isoforms Generated by Alternative Splicing 
Two J1-160/180 isoforms are generated from one single copy 
rat J1.1601180 
moulm tenll~In 
-  Q 
'~....l  l  l  ,  l  l  l  l  ,  ,  ,  l  [~12l;"|,]sk.~elTI8  COO. 
Figure 9. Schematic representation of the modular structure of rat 
11-I60/I80 in comparison to mouse tenasein. The cysteine  residues 
in the amino-terminal region are indicated by vertical lines. EGF- 
like domains arc symbolized  by small boxes, FNIII ~ts  by large 
boxes, and the domain homologous  to fibrinogen  by a filled circle. 
The bold-bordered box within the FNIII repeats represents alterna- 
tively spliced FNIII repeats. 
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tween the fifth and seventh repeat.  The position of the alter- 
natively spliced FNIII repeat and the fact that each of the 
constitutive FNIII repeats of J1-160/180 is most homologous 
to the corresponding one in tenascin may suggest that J1- 
160/180 and tenascin are derived from a common ancestor 
during  ewlution.  Unexpectedly,  the  alternatively  spliced 
sixth repeat in J1-160f180 did not reveal highest homology 
with one of  the alternatively  spliced FNIII repeats of tenascin 
from mouse (Weller et al., 1991) and human (Gulcher et al., 
1991).  Because of the  structural  similarities  between J1- 
160/180 and tenascin in alternative splicing of FNIII repeats, 
we would like  to introduce a  nomenclature  of the FNIII 
repeats  in  J1-160/180 as  recently  described by Vrucinic- 
Filippi and Chiquet-Ehrismann  (1992) for tenascin,  where 
the constitutively expressed repeats are designated  by nu- 
merals and the alternatively  spliced ones by capital letters. 
Since there is no counterpart for the sixth JM60/180 FNIII 
repeat in tenascin,  we termed it FNIII repeat X. This repeat 
was not found to be significantly  more similar to any other 
J1-160/180 repeat than  to those in tenascin and  it seems, 
therefore, unlikely that it was generated through  a recent 
reduplication of an FNIII unit as suggested for four of the al- 
ternatively spliced FNIH repeats in tenascin (Gulcher et al., 
1990). The result of this comparison could indicate that the 
alternatively spliced repeats are either not highly conserved 
or that in tenascin additional,  yet undiscovered  alternatively 
spliced repeats exist. In case of the first alternative,  it is pos- 
sible that the alternatively  spliced FNIII repeat in J1-160/180 
may  code  for  functional  properties  that  distinguish  J1- 
160/180 from tenascin. 
It is at present difficult to determine the relationship  be- 
tween the isoforms described at the protein level with an ap- 
parent molecular weight of 180 and 160 kD and the two iso- 
forms found at the DNA level, with calculated  molecular 
masses of 149 and 139 kD. Removal of N-linked  carbohy- 
drates by glycopeptidase F treatment  yielded protein bands 
at •160  and 140 kD by SDS-PAGE (B, Fuss and P. Pesheva, 
unpublished  results). Since O-glycosidically bound oligosac- 
charides have been suggested  for J1-160/180 (Wing et al., 
1992), it is possible that these are responsible for the differ- 
ence between the calculated molecular masses and the ap- 
parent  molecular weights  of the glycopeptidase F-treated 
proteins.  We therefore propose that the 160-kD glycoprotein 
isoform corresponds to the smaller DNA-derived isoform 
and that the larger glycoprotein isoform of 180 kD may then 
correspond to the larger  DNA-derived isoform. 
The existence of additional J1-160/180 isoforms generated 
by alternative  splicing cannot be excluded and it is still un- 
clear  whether  the glycoprotein component of ,'~  kD, 
known to copurify with the 160 and 180 kD components of 
J1-160/180 (Pesheva et al.,  1989),  represents  such an iso- 
form.  Additionally,  alternative  splicing  may occur in  the 
amino-terminal  portion of the protein, since it is likely that 
the difference in the association of the monomeric arms of 
J1-160/180, resulting in the structural appearance of trimers, 
dimers  and  monomers,  could  be generated  by different 
amino terminal structures.  Attempts to determine the amino- 
terminal sequences of the two major Jl-160/180 glycoprotein 
isoforms (160 and 180 kD) by protein sequencing have so far 
failed,  most probably due to blocked amino termini.  Thus, 
it  remains  to  be conclusively shown which alternatively 
spliced regions are represented in the different glycoprotein 
isoforrns and whether alternative  splicing alone is responsi- 
ble for generating  the different J1-160/180 isoforms. 
For  restfictin,  alternative  splicing  in  the  cysteine-rich 
amino-terminal  part was described, suggesting that the gen- 
eration  of these  isoforms plays  an  important  role in  the 
modification  of multimerization,  i.e.,  formation  of trimers 
and dimers, observed for J1-160/180 and restrictin  by elec- 
tron  microscopic analysis  of rotary  shadowed  molecules 
(Pesheva et al.,  1989; N6renberg et al.,  1992). Because of 
the genomic organization  of J1-160/180 (D. Montag, unpub- 
lished observations) it appears unlikely that isoforms differ- 
ing in the amount of amino-terminal  cysteine residues are 
generated by alternative  splicing  in JM60/180 at the same 
position as in restfictin. Alternative splicing of FNIII repeats 
has not been described for restrictin.  It remains  to be seen 
whether both types of isoforms are generated in both species 
and whether additional  isoforms  exist. 
Cellular Synthesis of  J1-160/180 
For  a  secreted  extracellular  matrix  protein,  such  as  J1- 
160/180, it is not only important to know which cells carry 
detectable levels of  the protein, but also which cell types syn- 
thesize the molecule.  The J1-160/180 glycoprotein has so far 
been detected immunocytochemically in  association with 
oligodendrocytes and white matter tracts in the central  ner- 
vous system (Pesheva et al.,  1989; Morganti  et al.,  1990). 
In agreement with these observations, the present study has 
localized Jl-160/180-specific  mRNA in cells with a similar 
distribution as the MAG-expressing oligodendrocytes (Stern- 
berger et al., 1979). The spatio-temporal  appearance of J1- 
160/180-expressing  cells in the prospective white matter and 
in the white matter tract of the developing and adult cerebel- 
lum closely resembles the immigration  of oligodendrocytes 
from the subependymal layer of the 4th ventricle via the su- 
perior medullary velum and the cerebellar peduncles (Rey- 
nolds and Wilkin,  1988),  further confirming  the oligoden- 
drocyte-derived expression of  J1-160/180. Interestingly, there 
is the tendency at earlier developmental stages for more cells 
showing detectable levels of J1-160/180 coding mRNA than 
for cells showing MAG coding mRNA. Thus,  in the three 
brain regions analyzed expression of J1-160/180 in oligoden- 
drocytes precedes the expression of MAG. The oligodendro- 
cyte-derived expression of Jlq60/180 is highest between the 
second and third postnatal week and low in the adult. These 
findings are in agreement with in vitro studies demonstrating 
that oligodendrocyte precursor cells and immature  oligo- 
dendrocytes express J1-160/180 before they express MAG, 
whereas  J1-160/180 expression  decreases.with  increasing 
maturity of the oligodendrocytes (Jung et al., submitted for 
publication).  The observations  are also consistent with the 
results obtained by in situ hybridization  in the optic nerve 
and spinal cord (Wintergerst  et al.,  1993), by immunocyto- 
chemistry and immunochemistry in the retina and optic nerve 
(Bartsch,  U., and P. Pesheva, manuscript submitted for pub- 
lication)  and by Northern blot analysis of CNS RNA ffuss 
et al., 1991). The synthesis of  Jl-160/180--specific mRNA co- 
inciding with the time of active myelination is suggestive of 
an important role of J1-160/180 during myelination  (for fur- 
ther discussion see Bartsch et al., submitted for publication). 
Astrocytes,  with the exception of type-2 astrocytes which 
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tence in vivo is still a matter of discussion (Noble,  1991), 
have so far never been seen to synthesize J1-160/180, neither 
by immtmocytochemical  nor by in situ hybridization studies 
(Pesheva et al., 1989; Wintergerst et al., 1993; Jung, M., P. 
Pesheva, M. Schachner, and J. Trotter, manuscript submitted 
for publication). 
J1-160/180 is not only expressed by oligodendroglial cells, 
but also by subpopulations of neurons. The neuronal expres- 
sion of J1-160/180 could be demonstrated in tissue sections 
of brain regions with unequivocally identifiable localization 
of neuronal cell bodies, such as the cerebellum, hippocam- 
pus, and olfactory bulb, and by comparison of the pattern of 
distribution of  Jl-160/180-positive cells with that of cells ex- 
pressing the neuronal marker L1 and the oligodendroglial 
marker MAG. Furthermore, acutely dissociated single cell 
suspensions of these brain regions were double labeled with 
the J1-160/180 anti-sense RNA by in situ hybridization and 
with the neuronal markers N-CAM180 and neurofilament 
by indirect immunofluorescence. These experiments clearly 
demonstrated that J1460/180  is expressed by some subtypes 
of neurons in the three brain regions analyzed. The presence 
of Jl-160/180-specific mRNA in the cerebellar stellate and 
basket cells was first detectable during the first postnatal 
week at a time where these cells are born and differentiate 
(Airman,  1982).  In the hippocampus and olfactory bulb, 
neuronal cell types expressing J1-160/180 could be identified 
by their distribution being similar to that of L1 expressing 
nerve cells. However,  a  more precise identification of the 
neuronal  subtypes  expressing  J1-160/180  by  anatomical 
criteria was not as unequivocal as in the cerebellum, since 
in the hippocampus Jl-160/180-positive neurons are located 
in a region of high diversity in neuronal cell types (Amaral 
and WiRer,  1989) and in the olfactory bulb the distribution 
of Jl-160/180-positive  neurons is not in conformity with the 
main neuronal cell types. Nevertheless, our observations in- 
dicate,  that  only  subpopulations  of neurons  express  JI- 
160/180. It is presently not dearly apparent why certain sub- 
populations of neurons  synthesize J1-160/180 in  different 
regions of  the CNS. Whether particular lineage relationships 
between oligodendrocytes and subpopulations of  neurons, as 
suggested during neurogenesis in the cerebral cortex (Wil- 
liams et al.,  1991), are instrumental in the expression of 
J1-160/180 by such diverse call types, or whether the Jl-160/ 
180-positive  neuronal  subpopulations  display  particular 
functional features, remains to be elucidated. 
J1-160/180 was originally characterized as an oligoden- 
drocyte-derived extracellular matrix protein (Pesheva et al., 
1989),  whereas restrictin was described as an extracellular 
matrix protein associated with axonal surfaces (Rathjen et 
al., 1991). Immunohistological  localization of restrictin was 
performed  using  sections  of  embryonic  chick  tissues, 
localizing it in the prospective white matter of the cerebel- 
lum, the inner and outer plexiform layer of the retina, and 
around motor neurons in the spinal cord (Rathjen et al., 
1991). This distribution is similar to the one described for 
J1460/180 in the rat and in the mouse by immunohistological 
methods and by in situ hybridization (Pesheva et al., 1989; 
Wintergerst et al.,  1992).  It remains to be seen whether in 
situ  hybridization using  a  restrictin-specific probe  yields 
similar results as those for J1-160/180. Thus, rat J1-160/180 
and chicken restrictin have a similar molecular structure and 
appear to be expressed in similar patterns in different struc- 
tures of  the CNS. However, not only similar but also different 
functional properties have been described for the two mole- 
cules. Both molecules interact or copurify with the neuronal 
cell adhesion molecule F3/ll (Rathjen et al., 1991; Pesheva 
et al., 1992).  No repellent properties for neurons have been 
reported for restrictin, neither for cell bodies nor for neurites 
(Rathjen et al., 1991), but have been observed for J1o160/180 
(Pesheva et al., 1989, 1992).  However,  since the two mole- 
cules were tested under different experimental conditions, 
further investigations are necessary to show whether the two 
molecules are not only structurally, but also functionally 
highly related. 
Since the expression of  J1-160/180 and tenascin is differen- 
tially regulated during development, it is tempting to specu- 
late that an important determinant of the molecules' func- 
tions, namely whether they are repellent or adhesive, could 
reside in the temporal and spatial context of  their expression. 
With the eDNA clones now available it is possible to study 
these contrary phenomena at the cellular and molecular lev- 
els, In addition, the common structural motifs of the known 
members of the J1  family will assist the search for other 
members of the family. 
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Note Added in Proof. Recently we have renamed J1-160/180 glycoprotein 
Janusin  (Fawcett,  J.  W.,  N.  Fersht,  L.  Housden,  M.  Schachner,  P. 
Pesheva. 1992. s  Cell Sci.  103:571-579; Wintergerst, E.-S., B. Fuss, U. 
Bartseh.  1993.  Fur. J. Neurosci.  In press; Batn.sch, U., P. Pesheva, M. 
Raft, M. Sehachner. 1993.  G//a. In press). This name will be used in the 
future to designate the protein. 
References 
Altman, J.  1982. Morphological  development of the rat cerebellum and some 
of its mechanisms.  In The Cerebellum:  New Vistas. Palay,  S. L., and V. 
Chan-Palay, editors. Springer Vedag/Berlin, Heidelberg, New York. 8-49. 
Altmann, J., and S. Boyer.  1975. Postnatal development of the hippocampal 
dentate  gyrus  under  normal  and  experimental  conditions. In  The  Hip- 
pocampus. R. L. Isaacson, K. H. Pribrau, editors. Plenum Press, New York. 
95-122. 
Amaral, D. G, and M. P. Witter. 1989. The three-dimensional  organization 
of the hippocampal formation:  a review of anatomical data. Neuroscience. 
31:57I--591. 
Bartsch, S., U. Bartsch,  U. Dtrries, A. Faissner, A. Weller, P. Ekblom, and 
M. Sehachner.  1992. Expression of tenasein in the developing and adult 
corebellar cortex. J. Neurosci.  12:736-749. 
Bartsch, U., P. Pesheva, M. Raft, and M. Sehachner.  1993. Expression  ofjanu- 
sin 01-1601/180)  in the retina and optic nerve of the developing and adult 
mouse.  Gila. In press) 
Chirgwin, J. M., A. E. Przybyla,  R. J. MacDonald,  and W. J. Rutter.  1979. 
Isolation  of biologically  active ribonucleic  acid from sources enriched in 
ribonuclease.  Biochemistry.  18:5294-5299. 
Cox, E. C., B. Mfiller, and F. Bonhoeffer. 1990. Axonal guidance in the chick 
visual system: posterior tectal membranes induce collapse of growth cones 
from temporal retina.  Neuron.  4:31-37. 
Davies, J. A., G. M. W. Cook, C. D. Stern, and R. J. Keynes. 1990. Isolation 
from chick somites of a glycoprotein  fraction that causes collapse of dorsal 
The Journal  of Cell Biology,  Volume 120,  1993  i248 root ganglion growth cones. Neuron. 4:11-20. 
Devereux, J. P., P. Haebedi, and O. Smithies. 1984. A comprehensive set of 
sequence analysis programs for the VAX. Nucleic Acids Res.  12:387-395. 
Edalman, G. M. 1986. Cell adhesion molecules in the regulation of  animal form 
and tissue pattern. Ann. Rev.  Cell Biol.  2:81-116. 
Erickson, H. P., and J. L. Iglesias. 1984. A six-armed oligomer isolated from 
cell surface fibronectin preparations. Nature (Lond.).  311:267-269. 
Erickson, H. P., and M. A. Bourdon, 1989. Tenascin: an extracellular matrix 
protein prominent in specialized embryonic tissues and tumors. Ann. Rev. 
Cell Biol.  5:71-92. 
Faissner, A., and J. Kruse. 1990. J1/tenascin is a repulsive substrate for central 
nervous system neurons. Neuron. 5:627-637. 
Falssner, A., J. F~-'use,  R. Chiquet-Ehrismann, and E. Mackie. 1988. The high- 
molecular weight Jl glycoproteins are immunochemically related to tenas- 
cin. Differentiation.  37:104-114. 
Fuss, B.,  U.  Pott,  P.  Fischer,  M.  E.  Schwab,  and M.  Schachner.  1991. 
Identification  of a  eDNA clone specific  for the oligodendrocyte-derived 
repulsive  extracellular  matrix  molecule  Jl-1601180.  J.  Neurosci.  Res. 
29:299-307. 
Gatchalian, C.  L.,  M.  Schachner, and L  R.  Sanes.  1989.  Fibroblasts that 
proliferate near denervated synaptic sites in skeletal muscle synthesize the 
adhesive  molecules  tenascin  (J1), N-CAM, fibronectin, and a heparan sulfate 
proteoglycan. J.  Cell Biol.  108:1873-1890. 
Gribskov, M., and R. R. Burgess. 1986. Sigma factors from E. coil, B. subtilis, 
phage SP01,  and phage T4 are homologous proteins. Nucleic Acids Res. 
14:6745-6763. 
Gulcher, J. R., M. J. Alexakos, M, M. LeBeau, R. S. Lemons, and K. Stefans- 
son. 1990. Chromosomal localization of the human hexabrachion (tenascin) 
gene and evidence for  recent reduplication  within the gene.  Genomics. 
6:616-622. 
Gulcher, J. R., D. E. Nies, M. L  Alexakos, N. A. Ravikant, M. E. Sturgill, 
L. S, Marton, and K. Stefansson. 1991. Structure of  the human  bexabrachion 
(tenascin)  gena. Proc. Natl. Acad.  Sci.  USA.  88:9438-9442. 
Heijne yon, G.  1988.  Transcending the impenetrable: how proteins come to 
terms with membranes. Biochim.  Biophys.  Acta.  947:307-333. 
Jessell, T. 1988. Adhesion molecules and the hierarchy of neural development. 
Neuron.  1:3-13. 
Jones, F. S., S. Hoffman, B. A. Cunning,  ham, and G. M. Edelman. 1989.  A 
detailed structural model of cytotactin: protein homologies, alternative RNA 
splicing, and binding regions. Proc. Natl. Acad. Sci.  USA. 86:1905-1909. 
Keynes, R. J., and G. M. W. Cook. 1992.  Repellent cues in axon guidance. 
Curr.  Opinions  Neurobiol.  2:55-59. 
Kozak, M. 1984. Compilation and analysis of sequences upstream of the trans- 
lational  start site in eukaryotic mRNAs. Nucleic Acids Res.  12:857-872. 
Kruse, J., G. Kellhaner, A. Falssner, R. Timpl, and M. Schachner. 1985. The 
J1  glycoprotein:  a  novel nervous system cell  adhesion molecule of the 
L2/HNK-1 family. Nature (Lond.).  316:146-148. 
Kyte, J.,  and R.  F.  Doolittle.  1982.  A  simple method for displaying the 
hydropathic character of a protein. J. Mol. BioL  157:105-132. 
Lai, C., M. A. Brow, K. A, Nave, A. B. Noronha, R. H. Qnarles, F. E. Bloom, 
R. J.  Milner, and J. G.  Sutcliffe.  1987.  Two isoforms of IB236/myelin- 
associated glycoprotein, a cell adhesion molecule for postnatal neural devel- 
opment are produced by alternative splicing. Proc. Natl.  Acad.  Sci.  USA. 
84:4337-4341. 
Lawler, J., R. Weinstein, and R. O. Hynes. 1988. Cell attachment to throm- 
bospondin: the role of Arg-Gly-Asp, calcium, and integrin receptors. J. Cell 
BioL  107:2351-2361. 
Moos, M., R. Tacke, H. Scherer, D. Teplow, K. F~h, and M. Schachner. 
1988. Neural adhesion molecule L1 is a member of the immunoglobulin su- 
perfamily and shares binding domains with fibronectin,  Nature  (Lond,). 
334:701-703. 
Morganti, M. C., J. Taylor, P. Pesheva, and M. Schachner. 1990. Oligoden- 
drocyte derived J 1-160/180 extracellular matrix glycoproteins are adhesive 
or repulsive depending on the partner cell type and time of interaction. Exp. 
Neurol.  109:98-1 t0. 
Noble, M. 1991. Points of controversity in the O-2A lineage: clocks and type-2 
astrocytes, Glia.  4:157-164. 
Noble, M., M. Albrechtsen, C. Moiler, J.  Lytes, E.  Boek,  C. Goridis, M. 
Watanabe, and U. Rutishauser. 1985. Glial cells express N-CAM/D2-CAM- 
like polypeptides in vitro. Nature (Lond.).  316:725-728, 
NSrenberg, U., H. Wille, J. M. Wolff, R. Frank, and F. G, Rathjen.  1992. 
The chicken neural extracellular matrix molecule restrictin:  similarity with 
EGF-, fibronectin type III-, and fibrinogen-like motifs. Neuron. 8:849-863. 
Obar, R. A., C. A. Collins, J. A. Hammarback, H. S. Shpetner, and R. B. 
Vallee.  1990.  Molecular cloning of the microtubule-associated mechano- 
chemical enzyme dynamin reveals homology with a new family of GTP- 
binding proteins. Nature (Lond.).  347:256-261. 
Palay, S. L., and V. Chan-Palay. 1974. Cerebellar cortex, cytology and organi- 
ration. Springer Verlag, Berlin, Heidelberg, New York.  1-348. 
Persohn, E., and M. Schachner. 1987.  Immunoelectronmicroscopic localiza- 
tion of the neural cell adhesion molecules L1 and N-CAM during postnatal 
development of the mouse cerebellum. J.  Cell BioL  105:569-576. 
Pesheva, P.,  E.  Spiess,  and M.  Schachner.  1989.  Jl-160 and Jl-180 are 
oligodendrocyte-secreted nonpermissive  substrates for cell adhesion. J. Cell 
Biol.  109:1765-1778. 
Pesheva, P., G. Gennarini, C. Goridis, and M. Schachner, 1993.  The F3/ll 
cell adhesion molecule mediates the repulsion of neurons by the extracellular 
matrix glycoprotein J1-160t180. Neuron. In press. 
Prieto, A. L., F. S. Jones, B. A. Cunningham, K. L. Crossin, and G. M. Edel- 
man. 1990. Localization during development of alternatively spliced forms 
of cytotactin mRNA by in situ hybridization. J.  Cell Biol.  111:685-698. 
Rathjen, F., and M.  Schachner.  1984.  Immunocytological and biochemical 
characterization of a  new neuronal cell  surface component (L1  antigen) 
which is involved in cell  adhesion. EMBO  (Eur.  Mol.  Biol.  Organ.) J. 
3:1-10. 
Rathjen, F. G., J. M. Wolff, and R. Chiquet-Ehrismarm. 1991.  Restrictin: a 
chick neural extracellular matrix protein involved in cell attachment co- 
purifies with the cell recognition molecule F 11. Development.  113:151-164. 
Reynolds, R., and G. P. Wilkin. 1988. Development of macroglial calls in rat 
cerebellum. II.  An in situ immunohistochemical study of oligodendroglial 
lineage from precursor  to  mature  myelinating cell.  Development.  102: 
409--425. 
Salki, R. K., D. H. Gelfand, S. Stoffel, S, J. Scbaff, R. Higuchi, G. T. Horn, 
K. B.  Mullis, and H.  A.  Ehflich.  1988.  Primer-directed enzymatic am- 
plification  of DNA with a thermostable DNA polymerase. Science (Wash. 
DC). 239:487-491. 
Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Lab- 
oratory Manual. 2nd edition. Cold Spring Harbor Laboratory, Cold Spring 
Harbor, NY. 
Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing  with chain- 
terminating inhibitors. Proc. Natl. Acad.  Sci.  USA.  74:5463-5467. 
Schachner, M.  1990,  Functional implications of glial cell recognition mole- 
cules. In Neurobiology of Gila: Seminars in the Neurosciences. 2:497-507. 
Schachner, M. 1991. Neural recognition molecules and their influence on cellu- 
lar functions. In The Growth Cone, S. S. Kater, P. C. Letournean, and 
E. R. Macagno, editors. Raven Press, New York. 237-254. 
Schlosshauer, B. 1989. Purification  of neuronal cell surface proteins and gener- 
ation of epitope-specific  monoclonal antibodies against cell adhesion mole- 
cules. J. Neurochem.  52:82-92. 
Schwab,  M.  E.  1990.  Myelin-associated inhibiturs of neurite  growth and 
regeneration in the CNS.  Trends Neurosci.  13:452-456. 
Seilbeimer, B., and M. Schachner. 1988. Studies of adhesion molecules mediat- 
ing interactions between cells of the peripheral nervous system  indicate a ma- 
jor role for L1 in mediating sensory neuron growth on Schwann cells in cut- 
rare. J.  Cell BioL  107:341-351. 
Siri, A., B. Carnemolla, M. Saginati, A. Leprini, G. Casari, F. Baralle, and 
L. Zardi. 1991. Human  tenascin: primary structure, pre-mRNA splicing pat- 
terns and localization  of epitopes recognized by two monoclonal antibodies. 
Nucleic Acids Res.  19:525-531. 
Spring, J., K. Beck, and R. Chiquet-Ehrismann. 1989. Two contrary functions 
of tenascin: dissection of the active sites by recombinant tenascin fragments. 
Cell.  59:325-334. 
Sternberger, N. H., R. H. Quarles, Y, Itoyama, and H. deF. Webster. 1979. 
Myelin-associated  glycoprotein demonstrated immunocytochemically  in my- 
elin and myelin-forming  cells of developing rat. Proc. Natl. Acad. Sci. USA. 
76:1510-1514. 
Vracinic-Filipi, N., and R. Chiquet-Ehrismann. 1993. Tenascin function and 
regulation of expression. J.  Cell Sci.  In press. 
Weller, A., S. Beck, and P. Ekblom.  1991.  Amino acid sequence of mouse 
tenascin and differential expression  of two tenascin isoforms  during embryo- 
genesis. Z  Cell Biol.  112:355-362. 
Wenger, R. H., M. Ayane, R. Bose, G. K6b.ter, and P. J. Nielsen. 1991. The 
genes for a mouse  hematopoietic differentiation  marker called the heat-stable 
antigen. Eur.  J. lmmunol.  21:1039-1046. 
Williams, B. P,, J, Read, and J. Price.  1991.  The generation of neurons and 
oligodendrocytes from a common precursor cell.  Neuron. 7:685-693. 
Wing, D. R., T. W. Rademacher, B. Schmitz, M. Schachner, and R. A. Dwek. 
1992.  Comparative glycosylation in neural adhesion motecules. Biochem. 
Soc.  Transactions.  20:386-390. 
Wintergerst, E.-S., B. Fuss, and U. Bartsch. 1993.  Localization of Janusin 
mRNA in the central nervous system  of  the developing and adult mouse. Fur. 
J. Neurosci.  In press. 
Fuss et al. Molecular Characterization  of J1-160/180  I249 